Social media

Central laboratories are under more pressure than ever. Increasingly complex protocols, frequent amendments, and growing data demands require speed, agility, and uncompromising scientific integrity. At ICON Laboratories,...

The annual J.P. Morgan Healthcare Conference convenes thousands of healthcare investors, global industry leaders and technology innovators to explore the key trends shaping the industry in 2026 and beyond. If you would ...

Early phase neurodegenerative trials require careful planning, a patient-first approach, and biomarker strategies that drive progress. Tune in to our recent ASCPT-hosted webinar, where we explored: - How to define target...

Site activation can take months. Learn how ICON is helping sponsors cut timelines in half with AI-powered tools and site-centric planning. Read the whitepaper: https://ow.ly/3w8u50XB70W

CRAs are no longer just monitors, they’re strategic site partners. Discover how tech is driving this shift in this ACT article featuring ICON’s Helen Yeardley. https://ow.ly/3qob50XB6Vo

ICON Concierge Services delivers on reducing burden while maintaining data quality. In a hybrid VMS study with 1,000 participants, our Concierge Services provided support to patients and sites, enabling a digital health ...

One of the most valuable Journals & Congresses features is Watchlists. The system will send you updates on your priority list whenever updated information is available. Deadline changes, location confirmation, detail upd...

Analysts, rejoice. Metys® offers predefined dashboards for quick answers and a powerful report builder for custom views – plus Excel integration for seamless workflows. It’s market intelligence, your way. Explore Mety...

Although advances in antiretroviral therapies are helping to curtail the HIV epidemic, there are limitations introduced by access and adherence. Find out what developers need to know when navigating these obstacles in th...

In settings with global HIV treatment disparities, the long-term success of antiretroviral interventions is jeopardised. Discover considerations for developing therapies that overcome obstacles in access, adherence and...

How to navigate EU MAA Regulations and Registration. Regulatory legislation in China differs substantially from that of the European Union. For Chinese biotech companies looking to enter the market it is critical to as...

Want to know what’s missing in next-gen drug delivery? In this article for BioPharm International, ICON’s Head of Regulatory CMC, Venkat Sunkara, outlines current product development trends happening in the world of bio...